Galena Biopharma Inc (GALE): Should You Buy the Hype Surrounding This Product Launch?
While the analysis of peak sales and potential patient populations may be appealing to most, it costs a great deal of money to launch a new product with success.
Amarin Corp Plc (AMRN)
Market is closed
News
- First
- << Previous
- 61 - 70
- Next >>
Amarin Corporation plc (ADR) (AMRN), AstraZeneca plc (ADR) (AZN), Omthera Pharmaceuticals Inc (OMTH): Three Stocks Near 52-Week Lows Worth Buying
Just as we examine companies each week that may be rising past their fair value, we can also find companies potentially trading at bargain prices.
Amarin Corporation plc (ADR) (AMRN): Something Fishy? Or Business as Usual?
There's no way this is good news for Amarin.
Nokia Corporation (ADR) (NOK): Here's What This Top-Earning Billionaire Has Been Buying
Today, let's look at Moore Capital Management, managed by billionaire Louis Moore Bacon.
Amarin Corporation plc (ADR) (AMRN), AstraZeneca plc (ADR) (AZN): A Winning Biotechnology Bet
Amarin Corporation plc (ADR) (NASDAQ:AMRN) has recently launched its primary product candidate Vascepa into the market.
AstraZeneca plc (ADR) (AZN)’s Acquisition of Omthera Pharmaceuticals Inc (OMTH) Is a Desperate Act
AstraZeneca plc (ADR) (NYSE:AZN) announced the acquisition of Omthera Pharmaceuticals Inc (NASDAQ:OMTH), a company that went public just last month (April 11).
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Why You Should Care About This Diabetes Drug Saga
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
Orexigen Therapeutics, Inc. (OREX): Are Hedge Funds Right About This Stock?
To the average investor, there are plenty of methods shareholders can use to monitor their holdings. A pair of the most useful are hedge fund and insider trading interest.
Amarin Corporation plc (ADR) (AMRN), Lexicon Pharmaceuticals, Inc. (LXRX): Which of These Billion-Dollar Biotechs Is a Buy?
It has been a rough year for Amarin Corporation plc (ADR) (NASDAQ:AMRN) and its long-term investors.
Amarin Corporation plc (ADR) (AMRN): This Drugmaker Should Go Fishing for a Marketing Partner
The biotechnology sector is rapidly evolving, and what was a near-guarantee of success of getting a drug approved by the Food and Drug Administration 10 years ago is no longer a guarantee.
- First
- << Previous
- 61 - 70
- Next >>
Billionaire Hedge Funds
